Cavalry 9

Immunity is also provided as an aid in the prevention of diseases caused by the beta and epsilon toxins of an additional organism, C. perfringens Type B. Although C. perfringens Type B is not a significant problem in North America (US), immunity is derived from a combination of Type C (beta) and Type D (epsilon) C. perfringens fractions.

Administration And Dosage

Shake well. Inject 2 mL subcutaneously followed by a 2 mL dose in 3 weeks. Calves vaccinated at 3-6 months of age should be given a 3^rd vaccination with either this vaccine, or another vaccine containing C. perfringens Type D epsilon toxoid, to aid in the prevention of disease caused by C. perfringens Type D. Revaccinate annually with 2 mL prior to periods of extreme risk or parturition.

Warnings

Store at 35°-45°F (2°-7°C). Do not freeze. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Anaphylactic reactions may occur following use.